CEL-SCI CORPORATION Conversion of Stock, Shares Issued
CEL-SCI CORPORATION (CVM) reported Conversion of Stock, Shares Issued of 41.10 thousand shares for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2025-12-29
- CEL-SCI CORPORATION conversion of stock, shares issued for fiscal 2025 was 41.10K shares, a 800.92% increase from fiscal 2024.
- CEL-SCI CORPORATION conversion of stock, shares issued for fiscal 2024 was 4.56K shares, a 95.30% decline from fiscal 2023.
- CEL-SCI CORPORATION conversion of stock, shares issued for fiscal 2023 was 97.00K shares, a 83.43% increase from fiscal 2022.
- CEL-SCI CORPORATION conversion of stock, shares issued for fiscal 2022 was 52.88K shares, a 193.95% increase from fiscal 2021.
| Period end | Conversion of Stock, Shares Issued 12 month | Conversion of Stock, Shares Issued 12 month as first filed |
|---|---|---|
| 2025-09-30 | 41.10K shares 10-K · filed 2025-12-29 | |
| 2024-09-30 | 4.56K shares 10-K · filed 2025-12-29 | 136.87K shares 10-K · filed 2025-01-13 |
| 2023-09-30 | 97.00K shares 10-K · filed 2025-01-13 | |
| 2022-09-30 | 52.88K shares 10-K · filed 2023-12-21 | |
| 2021-09-30 | 17.99K shares 10-K · filed 2022-12-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |